Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The impact of poly-substance use on the crosstalk between microglia, astrocytes, and neurons that regulates HIV latency

Award Number: R01DA060489
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/15/2024
PERIOD OF PERFORMANCE END DATE: 02/28/2029

Group Awards By:

View Award Description

The impact of poly-substance use on the crosstalk between microglia, astrocytes, and neurons that regulates HIV latency - Background. This proposal entitled “The impact of poly-substance use on the crosstalk between microglia, astrocytes, and neurons that regulates HIV latency is submitted in response to RFA-DA-24-001: Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use”. Although combination antiretroviral therapy (ART) dramatically lowers the levels of HIV RNA in the brain, it does not reduce the prevalence of HIV- associated neurocognitive disorders (HAND), which still develops in up to 50% of people with HIV (PWH). Poly- substance use in PWH increases the risk of developing HAND, creating a significant unmet medical challenge. Our goal. Our proposed ex vivo studies of poly-substance exposure are based on newly developed methods to derive authentic microglia, astrocytes, and neurons from induced pluripotent stem cells (iPSC). We will study the responses of these cells to HIV and poly-substance exposure in mono-, di-, tri-cultures, and organoids. Our previous work has shown that HIV latency is established due to signals from healthy neurons and astrocytes that drive infected microglia into a homeostatic state. The latent virus becomes reactivated in response to inflammatory cytokines and neuronal damage. For example, adding methamphetamine (METH) at a physiologically relevant concentration (100 nM) to co-cultures of microglia and neurons induces HIV reactivation and neuronal damage. Also, it sensitizes HIV-infected microglia to reactivation by inflammatory stimuli such as TNF-α. We will test the hypothesis that poly-substance use (combinations of methamphetamine and opioids) deregulates the cortical/dopaminergic system and disrupts the homeostatic regulation of microglia, leading to HIV reactivation and increased neuronal damage. In addition to measuring the impact of poly-substance exposure on HIV reactivation, we will use single-cell RNA sequencing to study the changes in cellular signaling and activation induced by substance exposure. How will we advance the field? To define how intracellular signaling between neurons, astrocytes, and microglia is dysregulated by poly-substance exposure, we will first investigate how METH and opioids affect the expression of crucial signal/receptor pairs (CD200/CD200R, CX3XL1/CX3CR1, glucocorticoid/GR, DA/DRD1-5) in the presence or absence of HIV. In addition, since we discovered unexpectedly that adenosine is a potent silencer of HIV in iMG cells, we will investigate how extracellular ATP produced by neurotoxicity and astrocyte activation is metabolized to adenosine by surface receptors on microglial cells and promotes HIV silencing. Understanding these mechanisms at the molecular level will set the stage for devising effective anti-inflammatory strategies to ameliorate HAND in the context of poly-substance use. challenging studies because it is only by working within the context of We are undertaking these technically authentic human microglial cells in an environment that better reflects the HIV-infected CNS that the underlying physiology is accurately represented.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $708,638 )
2026	2026	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Drug Use and Addiction Research Programs	000	3	2/26/2026	NON-COMPETING CONTINUATION	$708,638
														Subtotal = $708,638

Issue Date FY: 2025 ( Subtotal = $708,638 )
2025	2025	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Drug Use and Addiction Research Programs	002	2	4/10/2025	NON-COMPETING CONTINUATION	$70,863
2025	2025	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Drug Use and Addiction Research Programs	001	2	3/3/2025	NON-COMPETING CONTINUATION	$637,775
2025	2024	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Drug Use and Addiction Research Programs	000	1	3/3/2025	NEW	$0
														Subtotal = $708,638

Issue Date FY: 2024 ( Subtotal = $708,638 )
2024	2024	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Drug Use and Addiction Research Programs	000	1	5/14/2024	NEW	$708,638
														Subtotal = $708,638

Grand Total All Awards = $2,125,914

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The impact of poly-substance use on the crosstalk between microglia, astrocytes, and neurons that regulates HIV latency

Award Number: R01DA060489

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/15/2024

PERIOD OF PERFORMANCE END DATE: 02/28/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer